The transaction will considerably enhance Aetna’s existence and capabilities as a company of Medicare Supplement insurance. The price is approximately $290 million. Aetna expects to finance the acquisition with available resources. Bertolini, Aetna’s chairman, President and CEO. ‘This important growth opportunity comes at a time when the Medicare populace is anticipated to increase as ‘Baby Boomers’ reach age 65. Medicare Health supplement is expected to be considered a fast-growing product in the arriving years as individuals seek reassurance for out-of-pocket costs and employers search for added retiree coverages.’ Joseph M.Research indicates that periprosthetic disease, also called ‘septic failure,’ is the leading reason behind total knee replacement revision and the second-leading reason behind total hip substitute revision in the U.S. ‘Every orthopaedic surgeon inevitably sees sufferers who come back with a issue such as stiffness or discomfort in the joint,’ stated Craig J. Della Valle, MD, associate professor of orthopaedic procedure, Rush University Medical Center and seat of the physician work group that created the guideline.